Method: Unstimulated saliva samples were collected from 60 patients with chronic periodontitis pre- and 3 months post-treatment and also from 29 periodontally healthy individuals. The presence of different adiponectin isoforms was determined in a native Western blot. Concentrations of salivary HMW adiponectin, IL-1β and IL-6 were measured using ELISA.
Result: Presence of all adiponectin isoforms (high, middle and low molecular weight) was confirmed for the first time in saliva. ELISA analysis showed that HMW adiponectin concentrations were significantly higher in periodontitis (19.1±21.1 ng/ml) compared to health (8.1±7.8 ng/ml) (p<0.001). Post-treatment HMW adiponectin concentrations were significantly reduced in periodontitis patients (12.0±14.3 ng/ml) compared to pre-treatment values (p<0.01). HMW adiponectin concentrations were significantly and positively correlated with saliva IL-1β (ρ=0.346, p<0.01) and IL-6 (ρ=0.369, p<0.001), as well as with PISA (ρ=0.404, p<0.001).
Conclusion: Salivary HMW adiponectin concentrations were significantly higher in periodontitis compared to periodontal health, and reduced after periodontitis treatment. Additionally, HMW adiponectin concentrations significantly correlated with salivary IL-6 and IL-1β concentrations and PISA. These findings could support a possible pro-inflammatory role for salivary HMW adiponectin in periodontal disease and its potential as a novel periodontitis biomarker. The work was supported by the IADR Young Investigator Research Award.